Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination

被引:176
作者
Bauer, T [1 ]
Jilg, W [1 ]
机构
[1] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany
关键词
hepatitis B vaccination; immune memory; HBsAg; Elispot;
D O I
10.1016/j.vaccine.2005.08.058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Long-term protection after hepatitis B vaccination is dependent on the persistence of a strong immunologic memory. In search of reliable markers for a hepatitis B surface antigen (HBsAg)-specific immunological memory we studied the cellular and humoral immune responses of 15 healthy individuals who were successfully vaccinated but had lost anti-HBs titers. To determine the reactivity of vaccine-induced HBsAg-specific T cells of both effector and memory phenotype CD4+/CD45RA+ and CD4+/CD45R0+ T cells, respectively, were isolated, stimulated with HBsAg and tested for IFN-gamma and IL-5-secretion by enzyme-linked immunospot assays (Elispot). To detect even small numbers of specific T cells, we enriched the appropriate subpopulation from the entire PBMC population. B cell memory was analysed by cocultivation of isolated B cells with CD4+ T cells and identification of anti-HBs-secreting cells by Elispot. All individuals were revaccinated and humoral and cellular responses were determined. The results showed significant numbers of HBsAg-specific memory T and B cells present in all vaccinees despite the absence of specific antibodies. Our data suggest that individuals who had lost their anti-HBs seropositivity still show immunologic T cell memory and that these T cells are able to trigger anti-HBs production of B cells activated by revaccination. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 23 条
[1]  
Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6
[2]   Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory [J].
Banatvala, J ;
Van Damme, P ;
Oehen, S .
VACCINE, 2000, 19 (7-8) :877-885
[3]   Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination:: Stimulation of the in vitro antibody response by interferon gamma [J].
Böcher, WO ;
Herzog-Hauff, S ;
Schlaak, J ;
zum Büschenfelde, KHM ;
Löhr, HF .
HEPATOLOGY, 1999, 29 (01) :238-244
[4]   Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection [J].
Bocher, WO ;
HerzogHauff, S ;
Herr, W ;
Heermann, K ;
Gerken, G ;
zumBuschenfelde, KHM ;
Lohr, HF .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :52-58
[5]   Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low [J].
Boxall, EH ;
Sira, JA ;
El-Shuhkri, N ;
Kelly, DA .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (07) :1264-1269
[6]   Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres [J].
Dentico, P ;
Crovari, P ;
Lai, PL ;
Ponzio, F ;
Safary, A ;
Pellegrino, A ;
Meurice, F ;
Di Pasquale, A ;
Tornieporth, N ;
Volpe, A ;
Icardi, G .
VACCINE, 2002, 20 (31-32) :3725-3730
[7]   Memory T cells and vaccines [J].
Esser, MT ;
Marchese, RD ;
Kierstead, LS ;
Tussey, LG ;
Wang, FB ;
Chirmule, N ;
Washabaugh, MW .
VACCINE, 2003, 21 (5-6) :419-430
[8]   Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen [J].
Huang, LM ;
Chiang, BL ;
Lee, CY ;
Lee, PI ;
Chi, WK ;
Chang, MH .
HEPATOLOGY, 1999, 29 (03) :954-959
[9]   DECLINE OF ANTI-HBS AFTER HEPATITIS-B VACCINATION AND TIMING OF REVACCINATION [J].
JILG, W ;
SCHMIDT, M ;
DEINHARDT, F .
LANCET, 1990, 335 (8682) :173-174
[10]   Recombinant hepatitis B vaccine (Engerix-B®) -: A review of its immunogenicity and protective efficacy against hepatitis B [J].
Keating, GM ;
Noble, S .
DRUGS, 2003, 63 (10) :1021-1051